01 1PolyPeptide Group
01 1LINACLOTIDE DRUG SUBSTANCE
01 1Switzerland
01 1Active
01 1Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25021
Submission : 2011-06-01
Status : Active
Type : II
20
Polypeptide Laboratories Sweden Ab, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LINACLOTIDE DRUG SUBSTANCE, with a corresponding US DMF Number 25021.
Remarkably, this DMF maintains an Active status since its submission on June 01, 2011, highlighting commitment to regulatory compliance.
